Effect of Antiviral Treatment with Entecavir on Age- and Dose-Related Outcomes of Duck Hepatitis B Virus Infection

Entecavir (ETV), a potent inhibitor of the hepadnaviral polymerases, prevented the development of persistent infection when administered in the early stages of duck hepatitis B virus (DHBV) infection. In a preliminary experiment, ETV treatment commenced 24 h before infection showed no significant ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Foster, Wendy K., Miller, Darren S., Scougall, Catherine A., Kotlarski, Ieva, Colonno, Richard J., Jilbert, Allison R.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2005
Subjects:
Vaccines and Antiviral Agents
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1082753/
https://ncbi.nlm.nih.gov/pubmed/15827196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.9.5819-5832.2005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items